Company intelligence / Profile preview

SFL

Basel, Basel-Stadt, Switzerland

Ownership: Private
Employees: ~80
Development stage: Other

Overview

SFL supports international life sciences and pharmaceutical companies with regulatory, quality assurance, clinical trial strategy, market entry, pharmacovigilance, and other functions. It is recognized for expertise with orphan, rare disease and oncology therapies within Swiss/EU/UK markets.

Therapeutic areas: OncologyRare Diseases
Modalities: small moleculesbiologicsdevicesdiagnosticsadvanced therapies
Industry: Contract Research Organization

Partnerships

Rare Disease Action ForumSwiss BiotechEuropaBioMedtech & Pharma PlatformSWISS MEDTECHBritish-Swiss Chamber of Commerce

Beyond the preview

Go deeper on SFL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SFL.

Explore the full profile